Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type.

[1]  M. Follettie,et al.  Regulation of gene expression in mouse macrophages stimulated with bacterial CpG‐DNA and lipopolysaccharide , 2002, Journal of leukocyte biology.

[2]  E. Gilbert-Barness,et al.  Aluminum Phagocytosis in Quadriceps Muscle following Vaccination in Children: Relationship to Macrophagic Myofasciitis , 2002, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[3]  F. Authier,et al.  Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. , 2001, Brain : a journal of neurology.

[4]  D. Ranoux,et al.  Central nervous system disease in patients with macrophagic myofasciitis. , 2001, Brain : a journal of neurology.

[5]  M. Ulanova,et al.  The Common Vaccine Adjuvant Aluminum Hydroxide Up-Regulates Accessory Properties of Human Monocytes via an Interleukin-4-Dependent Mechanism , 2001, Infection and Immunity.

[6]  T. Curiel,et al.  Macrophage-Derived Dendritic Cells Have Strong Th1-Polarizing Potential Mediated by β-Chemokines Rather Than IL-121 , 2000, The Journal of Immunology.

[7]  D. Dormont,et al.  Na+-Dependent High-Affinity Glutamate Transport in Macrophages1 , 2000, The Journal of Immunology.

[8]  J. Hamilton,et al.  Particulate adjuvants can induce macrophage survival, DNA synthesis, and a synergistic proliferative response to GM‐CSF and CSF‐1 , 2000, Journal of leukocyte biology.

[9]  P. Laforêt,et al.  Macrophagic myofasciitis: an emerging entity , 1998, The Lancet.

[10]  K. Palucka,et al.  Dendritic cells as the terminal stage of monocyte differentiation. , 1998, Journal of immunology.

[11]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[12]  H. Bluethmann,et al.  In interleukin‐4‐deficient mice, alum not only generates T helper 1 responses equivalent to Freund's complete adjuvant, but continues to induce T helper 2 cytokine production , 1996, European journal of immunology.

[13]  Liangji Zhou,et al.  CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Liangji Zhou,et al.  A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. , 1992, Journal of immunology.

[15]  J. White,et al.  Predicting the adsorption of proteins by aluminium-containing adjuvants. , 1991, Vaccine.

[16]  G. Zlabinger,et al.  Modulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: effect on antigen uptake and antigen presentation. , 1985, Clinical and experimental immunology.

[17]  D. Hume,et al.  Macrophage activation by immunostimulatory DNA. , 2000, Current topics in microbiology and immunology.

[18]  Vaccine safety. Vaccine Safety Advisory Committee. , 1999, Releve epidemiologique hebdomadaire.

[19]  P. Chérin,et al.  [Macrophagic fasciitis: a new entity. Groupe d'études et recherche surles maladies musculaires acquises et disimmunitaires (GERMMAD) de l'association française contre les myopathies (AFM)]. , 1998, La Revue de medecine interne.

[20]  R. Gupta,et al.  Adjuvant properties of aluminum and calcium compounds. , 1995, Pharmaceutical biotechnology.